StudyRareStudyRare

Oculocutaneous albinism (OCA)

Log in to star

Last updated Nov 3, 2026

Log in to add personal notes on this page.

A newborn has white hair, very pale skin that does not tan, and pink-blue irides. Pediatric ophthalmology finds nystagmus, foveal hypoplasia, and reduced visual acuity (~20/100). Parents are unaffected; the child has no abnormal bleeding or recurrent infections.

AR (all nonsyndromic OCA); biallelic loss-of-function variants in genes for melanin synthesis, most often TYR (tyrosinase), OCA2, and SLC45A2 (MATP). Subtypes by gene:

SubtypeGenePigment phenotypeNotes
OCA1ATYR (null)No pigment ever, white hair lifelongMost severe; tyrosinase activity absent
OCA1BTYR (residual)Some pigment by adulthoodTyrosinase partially functional
OCA2OCA2 (P gene)Pigment develops over timeWith TYRP1, the most common cause in sub-Saharan Africa; includes "brown" OCA
OCA3TYRP1Red-bronze skin, ginger-red hair; formerly "rufous albinism"More common in African populations
OCA4SLC45A2VariableMost common OCA in Japan

In OCA, impaired melanin biosynthesis lowers pigment in the skin, hair, and eyes. Tyrosinase is the rate-limiting enzyme of melanin synthesis.

  • TYR (OCA1, 42% of OCA in mostly European series): OCA1A is absent or completely inactive enzyme, with severe loss of retinal, iris, and skin pigment. OCA1B comes from hypomorphic variants that leave some activity, so pigment ranges up to near normal.
  • SLC45A2 (OCA type 4, 11%) and OCA2 (OCA type 2, 28%): SLC45A2 encodes MATP, a membrane protein expressed only in melanocytes that appears to govern tyrosinase processing, its trafficking to melanosomes, and melanosome pH. Tyrosinase appears to be mislocalized in mouse melanocytes homozygous for SLC45A2 variants, as in melanocytes with OCA2 variants. In one series of 30 people with OCA4, biallelic nonsense or frameshift variants gave a picture indistinguishable from OCA1 and at least one missense variant gave a milder one; the common Japanese missense variants p.Asp157Asn and p.Gly188Val keep minimal activity and give a severe phenotype.

Residual tyrosinase activity separates OCA1A from OCA1B, and variant class shifts OCA4 severity. The eye findings are foveal hypoplasia, misrouting of temporal retinal fibers across the optic chiasm, and iris transillumination, and visual acuity tracks the grade of foveal hypoplasia.

  • Skin/hair: pale white to cream; minimal-to-no tanning; lifetime sun-related skin cancer risk
  • Eyes:
    • Nystagmus (early infancy)
    • Iris transillumination
    • Foveal hypoplasia (low visual acuity, 20/60 to 20/200)
    • Optic nerve mis-routing (excessive crossing at chiasm): diagnostic on VEP
    • Strabismus, photophobia
  • No bleeding, no immune deficiency: these distinguish OCA from syndromic forms
  • Clinical (hypopigmentation + characteristic eye findings + foveal hypoplasia on OCT)
  • Molecular gene panel (OCA1–4 plus syndromic forms)
  • Hermansky-Pudlak syndrome (HPS): OCA + platelet storage pool defect (bleeding) + pulmonary fibrosis. Multiple subtypes; HPS-1 is severe, common in Puerto Ricans.
  • Chediak-Higashi syndrome: OCA + immunodeficiency + giant cytoplasmic granules + accelerated lymphoproliferative phase.
  • Griscelli syndrome: silvery hair + immunodeficiency or neurologic disease (depending on subtype).

If a patient with albinism has bleeding, immune issues, or pulmonary symptoms, the diagnosis is NOT OCA.

  • Skin protection: lifelong sun protection, annual dermatology screening for skin cancer
  • Vision: low-vision aids, refraction, classroom accommodations; tinted lenses for photophobia
  • Surveillance: rule out HPS in any patient with bruising; order platelet electron microscopy
  • Genetic counseling: AR, ~25% recurrence risk

"OCA = Only Cutaneous + Anatomical-eye": pure OCA has no platelet, immune, or pulmonary findings. Anything beyond skin and eyes points to a syndromic albinism (HPS, Chediak-Higashi, Griscelli).

Reference Links